Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer.

Vanharanta S, Shu W, Brenet F, Hakimi AA, Heguy A, Viale A, Reuter VE, Hsieh JJ, Scandura JM, Massagué J.

Nat Med. 2013 Jan;19(1):50-6. doi: 10.1038/nm.3029. Epub 2012 Dec 9.

PMID:
23223005
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

VHL and HIF signalling in renal cell carcinogenesis.

Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruïne AP.

J Pathol. 2010 Jun;221(2):125-38. doi: 10.1002/path.2689. Review.

PMID:
20225241
[PubMed - indexed for MEDLINE]
3.

The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease.

Haase VH.

Kidney Int. 2006 Apr;69(8):1302-7. Review.

PMID:
16531988
[PubMed - indexed for MEDLINE]
4.

The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma.

Kaelin WG Jr.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):680s-684s. Review.

PMID:
17255293
[PubMed - indexed for MEDLINE]
Free Article
5.

Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.

Maynard MA, Ohh M.

Am J Nephrol. 2004 Jan-Feb;24(1):1-13. Epub 2003 Dec 3. Review.

PMID:
14654728
[PubMed - indexed for MEDLINE]
Free Article
6.

[Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].

Zhang YT, Chen N, Zeng H, Zhou Q.

Zhonghua Bing Li Xue Za Zhi. 2006 Sep;35(9):562-4. Review. Chinese. No abstract available.

PMID:
17134554
[PubMed - indexed for MEDLINE]
7.

Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL.

Li M, Kim WY.

J Cell Mol Med. 2011 Feb;15(2):187-95. doi: 10.1111/j.1582-4934.2010.01238.x. Review.

PMID:
21155973
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Alterations in VHL as potential biomarkers in renal-cell carcinoma.

Gossage L, Eisen T.

Nat Rev Clin Oncol. 2010 May;7(5):277-88. doi: 10.1038/nrclinonc.2010.42. Epub 2010 Apr 6. Review.

PMID:
20368728
[PubMed - indexed for MEDLINE]
9.

VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment.

Rathmell WK, Chen S.

Expert Rev Anticancer Ther. 2008 Jan;8(1):63-73. Review.

PMID:
18095884
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.

Clark PE.

Kidney Int. 2009 Nov;76(9):939-45. doi: 10.1038/ki.2009.296. Epub 2009 Aug 5. Review.

PMID:
19657325
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Renal cancer: oxygen meets metabolism.

Haase VH.

Exp Cell Res. 2012 May 15;318(9):1057-67. doi: 10.1016/j.yexcr.2012.02.026. Epub 2012 Mar 3. Review.

PMID:
22406000
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The role of inflammation in kidney cancer.

de Vivar Chevez AR, Finke J, Bukowski R.

Adv Exp Med Biol. 2014;816:197-234. doi: 10.1007/978-3-0348-0837-8_9. Review.

PMID:
24818725
[PubMed - indexed for MEDLINE]
13.

Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma.

Czarnecka AM, Kornakiewicz A, Kukwa W, Szczylik C.

Future Oncol. 2014 May;10(6):1095-111. doi: 10.2217/fon.13.258. Review.

PMID:
24941992
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk